Search for: "Givens v. State" Results 101 - 120 of 53,317
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 May 2024, 4:00 am by Eric Segall
Wade, he invoked a surprising name given the case’s subject. [read post]
22 May 2024, 1:15 am by Charlie French (Bristows)
Although the Court of Appeal stated in Ocado v AutoStore that the interest of the general public usually arises after a decision is rendered, the position was different in this case as it might be too late for Nicoventures to use the information in the EPO proceedings if access was not granted immediately. [read post]
21 May 2024, 9:01 pm by renholding
Instead, rather than focusing on whether a particular interaction could be considered fiduciary investment advice, the Final Rule says it is the circumstances under which the advice is given, and whether those facts and circumstances would objectively be viewed as given in the context of a trusted relationship that will be determinative. [read post]
21 May 2024, 1:15 pm by Tobin Admin
If a policy exclusion is unambiguous, however, it must be given effect even if beneficial to the insurer and detrimental to the insured. [read post]
21 May 2024, 2:45 am by Rebecca Daramola (Bristows)
It stated that the documents of the EPO examination proceedings cited by the parties shed no new light on its interpretation. [read post]
20 May 2024, 10:30 pm by Jesse Peters
In line with previous case law such as In ‘t Veld v Council, the Court required [read post]
Notable Federal Court proceedings saw a win for ASIC in the first greenwashing civil penalty action and a finding that a term in an insurance contract was not unfair, which ASIC has given notice to appeal. [read post]
20 May 2024, 1:07 pm by David Pozen
Schedule I of the CSA imposes a complete criminal ban; schedules II through V allow drugs to be prescribed under certain conditions. [read post]
20 May 2024, 11:52 am by Bona Law PC
In the blog post, the FTC includes a previous Statement of Interest (“SOI”) filed in the Duffy v. [read post]
20 May 2024, 8:40 am by David Pozen
” Yet given this status quo, contemporary drug reformers have little to lose from pitching new legal arguments, not only or primarily to the Court but also to state judges and extrajudicial audiences. [read post]